via medpagetoday.com
The spokesperson said the agency planned to include a review of the labeling and indications for fenofibric acid (Trilipix). It should, however, be noted that the trial used fenofibrate (TriCor).
Both Trilipix and TriCor are marketed by Abbott, and Trilipix is "the active metabolite of TriCor," according to Marshall Elam, MD, PhD, of the Memphis VA Medical Center.
No comments:
Post a Comment